Cargando…
Impact of clozapine monotherapy on gut microbiota and metabolism in people with schizophrenia
BACKGROUND: Clozapine is considered one of the most effective antipsychotic drugs, but it is most likely to cause metabolic abnormalities. Researchers have studied the causes of metabolic abnormalities caused by clozapine from multiple perspectives, but the reasons remain unclear. PURPOSE: Character...
Autores principales: | Yin, Feiyan, Shi, Zhidao, Ma, Xiquan, Ding, Kai, Zhang, Yuan, Ma, Sha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512059/ https://www.ncbi.nlm.nih.gov/pubmed/37744899 http://dx.doi.org/10.3389/fmicb.2023.1253156 |
Ejemplares similares
-
Recovery journey of people with a lived experience of schizophrenia: a qualitative study of experiences
por: Ma, Min, et al.
Publicado: (2023) -
The psychometric properties of the barriers to insulin treatment questionnaire in Chinese patients with type 2 diabetes mellitus using insulin
por: Ma, Min, et al.
Publicado: (2023) -
Homocysteine Levels in Patients with Schizophrenia on Clozapine Monotherapy
por: Wysokiński, Adam, et al.
Publicado: (2013) -
Association Between SIRT1, Cytokines, and Metabolic Syndrome in Schizophrenia Patients With Olanzapine or Clozapine Monotherapy
por: Fang, Xinyu, et al.
Publicado: (2020) -
Serum levels of AgRP protein in patients with schizophrenia on clozapine monotherapy
por: Wysokiński, Adam, et al.
Publicado: (2014)